A direct comparison between the experimental psychedelic drug psilocybin and a standard SSRI antidepressant shows similar improvement of depressive symptoms, but that psilocybin offers additional longer-term benefits… Lead researcher Mr. Tommaso Barba (Ph.D. candidate from Imperial College, London) said, “This is the first work to compare the long-term effects of these two drugs in the…
By August 11 [2024], the Food and Drug Administration is expected to decide whether MDMA – the chemical found in ecstasy or molly – can be prescribed as a treatment for post-traumatic stress disorder. The downvote in June [2024] – not to mention controversy about the trials that spilled into full view during a public hearing –…
A 51-year-old Calgary man who suffers debilitating cluster headaches has won a Federal Court battle forcing Health Canada to reconsider his bid for legal access to psilocybin to treat his extreme pain. …the decision to deny Lance access to the drug “unreasonable” and “unintelligible.” Health Canada told Canadian Broadcasting Center News via email that it…
Here’s another… under-studied prospect of psychedelics: a world without severe chronic pain. And… around the internet or psychedelic conferences, a whole subterranean trove of similar stories opens up. An estimated 51 million Americans suffer from chronic pain – excruciating conditions like migraines, phantom limb pains, or fibromyalgia – and often go without effective treatments. But psychedelics like psilocybin mushrooms and LSD seem to…
Why the VA matters: It’s the largest health system in the country and serves a population with disproportionately high rates of PTSD. The VA announced in January [2024 that it would fund research into psychedelics like MDMA, also known as ecstasy, and psilocybin as potential treatments for post-traumatic stress disorder and depression. While outside groups have…
…this will… be the first time in 25 years that the FDA will review a new treatment for PTSD… The FDA is set to decide on the therapy’s fate by the middle of August [2024]… if rescheduled, then lobbying efforts will shift to individual states. Some have policies on the books that will immediately follow…
That question is now before one of the nation’s highest courts… …pitting the DEA’s law enforcement authority against state powers to regulate medicine… Washington, Washington D.C., Delaware, Illinois, Michigan, Minnesota, Nevada, Oregon and Pennsylvania… have weighed in directly… the state coalition filed a brief that accused the DEA of reaching far beyond its law enforcement…
MAPS PBC [Public Benefit Corporation) has rebranded to Lykos Therapeutics [a for-profit public benefit corporation (“PBC”)], (“Lykos”), the greek word for wolf. MAPS PBC spun out of its parent organization MAPS (Multidisciplinary Association for Psychedelic Studies)… clinical development effort of MDMA-assisted therapy [midomafetamine capsules used in combination with psychological intervention], which includes talk therapy, and…
Comparisons are drawn between the struggle for… magic mushrooms and the fight for cannabis. Eugene Oscapella, a criminology professor and lawyer, explains that the police have limited resources and face competing priorities. “We have stock nearby for emergencies,” said owner Edgars Gorbans, “After the raid, after one hour, the store was fully stocked up and…
“In California enforcement is not something happening when it comes to psilocybin products,” the founder of psilocybin gummy brand Cubiq tells Los Angeles magazine under the pseudonym “Maria Sabina”… “There are brands moving psilocybin all over the world,” Sabina says. “…the underground market has been thriving for many years with great demand.” According to Sabina, branded psychedelic products began…
Recent Comments